Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?

Elon Eisenberg, Dorit Pud

Research output: Contribution to journalArticlepeer-review

Abstract

The treatment of neuropathic pain remains a challenge as it rarely leads to long-term relief of symptoms. We report three patients with chronic neuropathic pain, in whom acute administration of the N-methyl-D-aspartate (NMDA) receptor antagonist amantadine resulted in complete resolution of symptoms, presumably due to termination the central 'wind-up' phenomenon.

Original languageEnglish
Pages (from-to)337-339
Number of pages3
JournalPain
Volume74
Issue number2-3
DOIs
StatePublished - Jan 1998

Keywords

  • 'wind-up' phenomenon
  • Amantadine
  • N-methyl-D-aspartate receptor
  • Neuropathic pain

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?'. Together they form a unique fingerprint.

Cite this